Corry R J, Egidi M F, Shapiro R, Sugitani A, Gritsch H A, Jordan M L, Dodson S F, Vivas C A, Scantlebury V P, Rao A S, Fung J J, Starzl T E
Starzl Transplantation Institute, University of Pittsburgh, Pennsylvania, USA.
Transplant Proc. 1998 Mar;30(2):521. doi: 10.1016/s0041-1345(97)01385-7.
In this series, antilymphoid induction therapy did not appear to be necessary to prevent early graft loss from rejection. In addition, we have followed cytomegalovirus (CMV) antigenemia (pp65) for CMV infection. Although some patients developed a positive antigenemia in the seropositive to negative donor-recipient combinations, only one patient had a prolonged febrile course for 1 week.
在本系列研究中，抗淋巴细胞诱导治疗似乎并非预防移植早期因排斥反应而丢失所必需的。此外，我们对巨细胞病毒（CMV）感染进行了CMV抗原血症（pp65）监测。尽管在供体血清学阳性而受体血清学阴性的组合中，一些患者出现了抗原血症阳性，但只有一名患者出现了持续1周的发热病程。
